genetics investing Telo Genomics Announces Non-Brokered Private Placement of Convertible Debentures for up to $1,200,000
genetics investing Telo Genomics Expands Operations with Relocation of Clinical Laboratories to New, Larger Toronto Facility and Provides Board Update
Quebec Innovative Materials Corp. Announces U.S. Affiliate Orvian Receives Minnesota DNR Registration for Exploratory Boring
